Status:
COMPLETED
The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit
Lead Sponsor:
Genesys
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Sepsis
Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.
Detailed Description
While evidence exists for using tight glycemic control in the critically ill cardiac surgical patient, other patient populations have yet to be studied. We performed a prospective randomized trial for...
Eligibility Criteria
Inclusion
- Patients undergoing a general or vascular surgical procedure requiring admission to the surgical intensive care unit as a result of ventilatory requirement, vasopressor support, or physiologic instability
- \-
Exclusion
- Under age 18
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT00282594
Start Date
July 1 2003
End Date
October 1 2005
Last Update
January 27 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genesys Regional Medical Center
Grand Blanc, Michigan, United States, 48439